Abstract: The invention provides compounds of Formula I, and methods of treating or preventing a bacterial infection in a subject using a compound of Formula I. The invention also provides the use of a compound of Formula I in the manufacture of a medicament for the treatment of a bacterial infection in a subject. The invention further provides a medical device when used in a method of treating or preventing a bacterial infection in a subject and to a medical device comprising the composition of the invention.

Abstract: A method of treating and/or preventing gastric ulcers, said method comprising administering by injection a therapeutically effective amount of a composition comprising: c) a first agent selected from the group consisting of: a medium chain triglyceride and a long chain triglyceride; and d) a second agent comprising a proton pump inhibitor or pharmaceutically or veterinary acceptable salt, wherein the composition is adapted for sustained release of a therapeutically effective amount of the proton pump inhibitor to a subject in need thereof.

Abstract: The invention is a method and composition for treating a topical microbial infection in a subject. The method includes the step of administering a therapeutically effective amount of a polyether ionophore, or a therapeutically acceptable salt thereof, to the subject.

Abstract: The invention relates to a liquid formulation comprising propylene glycol and an effective amount of an inodilator, an angiotensin converting enzyme inhibitor, or a combination of an inodilator and an angiotensin converting enzyme inhibitor and to use of the formulation for treating cardiac disease and/or hypertension.

Abstract: The invention relates to a liquid formulation comprising propylene glycol and an effective amount of an inodilator, an angiotensin converting enzyme inhibitor, or a combination of an inodilator and an angiotensin converting enzyme inhibitor and to use of the formulation for treating cardiac disease and/or hypertension.

Abstract: The invention provides compounds of Formula (I), and their use in methods for treating or preventing a protozoan infection in a subject using a compound of Formula (I). The invention also provides the use of a compound of Formula (I) in the manufacture of a medicament for the treatment of a protozoan infection in a subject. The invention further provides a medical device when used in a method of treating or preventing a protozoan infection in a subject and to a medical device comprising the composition of the invention.

Abstract: The invention comprises methods for treating and preventing a bacterial infection in a subject, methods for preparing a medicament for use in treating and preventing a bacterial infection in a subject, and pharmaceutical and veterinary antibacterial compositions when used therein.

Abstract: The invention comprises methods for treating and preventing a bacterial infection in a subject, methods for preparing a medication for use in treating and preventing a bacterial infection in a subject, and pharmaceutical and veterinary antibacterial compositions when used therein.

Abstract: The invention comprises methods for treating and preventing a bacterial infection in a subject, methods for preparing a medicament for use in treating and preventing a bacterial infection in a subject, and pharmaceutical and veterinary antibacterial compositions when used therein.

Abstract: The invention provides compounds of Formula (I), and methods of treating or preventing a bacterial infection in a subject using a compound of Formula (I). The invention also provides the use of a compound of Formula (I) in the manufacture of a medicament for the treatment of a bacterial infection in a subject. The invention further provides a medical device when used in a method of treating or preventing a bacterial infection in a subject and to a medical device comprising the composition of the invention.

Abstract: The invention comprises methods for treating and preventing a bacterial infection in a subject, methods for preparing a medicament for use in treating and preventing a bacterial infection in a subject, and pharmaceutical and veterinary antibacterial compositions when used therein.

Abstract: The invention is a method and composition for treating a topical microbial infection in a subject. The method includes the step of administering a therapeutically effective amount of a polyether ionophore, or a therapeutically acceptable salt thereof, to the subject.

Abstract: The invention includes methods and compositions for treating mastitis in a subject. The method includes the step of administering, by intramammary delivery, a therapeutically effective amount of a polyether ionophore, or a therapeutically acceptable salt thereof, to the mammary gland of the subject.

Abstract: The invention relates to a liquid formulation comprising propylene glycol and an effective amount of an inodilator, an angiotensin converting enzyme inhibitor, or a combination of an inodilator and an angiotensin converting enzyme inhibitor and to use of the formulation for treating cardiac disease and/or hypertension.

Abstract: Operation of an industrial vehicle, such as one that lifts and transports loads, is controlled based on the weight of a removable battery. A control method involves reading a battery weight value from an electronic memory attached to a battery. That battery weight value is compared to a specified battery weight value for the industrial vehicle. The operation of the industrial vehicle is restricted to less than the normal operating characteristics when the battery weight value is less than the specified battery weight value. For example, the height to which a load can be raised is limited or the speed at which the industrial vehicle is limited when a battery installed on the industrial vehicle weighs less than the specified battery weight for effectively counterbalancing a load.

Abstract: Operation of an industrial vehicle, such as one that lifts and transports loads, is controlled based on the weight of a removable battery. A control method involves reading a battery weight value from an electronic memory attached to a battery. That battery weight value is compared to a specified battery weight value for the industrial vehicle. The operation of the industrial vehicle is restricted to less than the normal operating characteristics when the battery weight value is less than the specified battery weight value. For example, the height to which a load can be raised is limited or the speed at which the industrial vehicle is limited when a battery installed on the industrial vehicle weighs less than the specified battery weight for effectively counterbalancing a load.

Abstract: ‘Violetty’ is a new variety of pelargonium having a trailing growth habit and numerous tri-colored flowers.

Abstract: ‘Violetty’ is a new variety of pelargonium having a trailing growth habit and numerous tri-colored flowers.

Abstract: A new and distinct cultivar of Filipendula plant named ‘Wbprest’, characterized by its compact, upright, broadly outwardly spreading and mounding plant habit; freely branching habit; green-colored leaves with dark greyed purple-colored venation; numerous light red purple-colored flowers; good garden performance; and low temperature hardiness.

Abstract: A new and distinct cultivar of Physostegia plant named ‘Nicauca’, characterized by its compact and upright plant habit; freely basal branching growth habit; long flowering period; purple-colored flowers arranged on dense terminal racemes; and good garden performance and winter hardiness.